Sarah Romano, Interim CFO at EYEGATE PHARMACEUTICALS INC (EYEG), bought 10,000 shares at $1.00 ($10K) on 2017-08-15, disclosed to the SEC on 2017-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ENTO | SELL | 2024-07-03 | $664 | — | Filing → |
| FWBI | SELL | 2024-04-03 | $317 | — | Filing → |
| FWBI | SELL | 2024-03-19 | $6K | — | Filing → |